A good adherence to ELN 09 recommendations in chronic myeloid leukemia (CML) treatment with imatinib, is associated with better outcomes in patients treated outside clinical trials
Servizos
Servizos
Data de publicación
2012Título da revista
Blood
Tipo de contido
Publicación de congreso
